Patients with diabetes who require more than 40 units of insulin per day are usually best controlled by giving a large dose of protamine zinc insulin and a smaller dose of regular (or crystalline) insulin, before breakfast, daily (1) . Standard protamine zinc insulin does not have sufficient rapid activity to control the hyperglycemia occurring after meals in patients with severe diabetes. In such cases, attempts to eliminate glycosuria during the day by increasing the dose of protamine zinc insulin tend to cause hypoglycemia during the night. When the diabetes is mild, requiring 40 units or less per day, the rise in the blood sugar after food intake may not be great, and a single dose of protamine zinc insulin daily may permit good regulation. A night feeding at 9 or 10 p.m. helps to prevent nocturnal hypoglycemia. Among 154 patients satisfactorily regulated during the period between January 1, 1940, and July 1, 1942, we found that "combined therapy," with separate daily injections of protamine zinc insulin and regular insulin, was necessary in 57 cases (37 per cent). In the period of 21/2 years, the average dose given the 97 patients requiring protamine zinc insulin alone was 24 units, while the average total daily requirement of the 57 patients needing combined therapy was 57 units. Of the 54 patients requiring more than 40 units of insulin daily, 47 (87 per cent) required combined therapy.
The primary objection to combined therapy is that it is a compromise, still requiring multiple 1 These studies were reported at the annual meeting of the Central Society for Clinical Research, Chicago, November 6, 1942 , in a paper entitled: "Three-to-One" Modified Protamine Zinc Insulin; An Improvement Upon Market Protamine Zinc Insulin.
2The non-standard forms of modified insulin used in these investigations were supplied by Eli Lilly and Company.
injections, thus partly nullifying one of the chief advantages of protamine zinc insulin. A second objection is that it requires manipulation by the patient of 2 very different forms of insulin and increases the possibilities of error. Many investigators have been aware of these objections and a number of studies of various insulin modifications have been reported.
Histone insulin, made by adding to insulin the simple protein, histone, obtained from thymus glands, was introduced by Hagedorn, Jensen, Krarup, and Wodstrup (2) . It was studied clinically by Biasotti, Deulofeu, and Mendive (3), and Gray, Bischoff, and Sansum (4). Barnes, Cuttle, and Duncan (5) studied histone insulin to which zinc had been added. They concluded that histone zinc insulin gave a prolonged effect, but was more prompt in onset of action than protamine zinc insulin. Bailey and Marble (6) found that a single adequate dose of histone zinc insulin before breakfast kept the fasting blood sugars within approximately normal limits in the 4 patients studied. Glycosuria was well controlled, and there was very little rise in the blood sugar after breakfast, but a considerable rise after lunch. They concluded that "the action of histone zinc insulin resembles closely that of turbid protamine zinc insulin except for the initial action just described and probably for a slightly less prolonged effect." Clear (soluble or acid) protamine zinc insulin has a pH of 3.3 to 3.5, at which the material is all in solution. It also contains more protamine and more zinc than turbid protamine zinc insulin. Bailey and Marble (6) , in a recent report of comparative studies in 4 patients, found that the fasting blood sugars were quite high and that regulation with clear protamine zinc insulin was difficult. They found that with it a relatively large increase in the blood sugar occurred between 7 and 11 a.m., with a fall between 11 a.m. and 2 p.m., and 791 a great decrease between 2 and 5 p.m., requiring a mid-afternoon lunch to prevent reactions.
Several investigators (6) have concluded that the use of globin insulin required a mid-afternoon lunch to prevent hypoglycemic reactions. This would make it unsatisfactory for many patients. An excellent review of the various types of modified insulin, with a table giving their descriptions, was presented by Colwell, Izzo, and Stryker (7).
The present paper presents our investigations of histone zinc insulin, clear (soluble or acid) protamine zinc insulin, and a new, more promising modified protamine zinc insulin.
SELECTION OF A STANDARD MODIFIED PROTAMINE ZINC INSULIN
In the 57 cases in our series requiring combined therapy with separate daily injections of protamine zinc insulin and regular insulin, the proportion of protamine zinc insulin to regular insulin ranged from 6: 1 to 1.2: 1, averaging 3: 1. Forty-five of the 57 (79 per cent) required a proportion between 2: 1 and 4: 1, while 29 (51 per cent) required between 2.5: 1 and 3.5: 1. Joslin (8) found that over 50 per cent of a recently analyzed series of diabetic patients required combined therapy, and that the average proportion needed was 3:1.
Because the studies here reported indicate that histone zinc insulin and clear protamine zinc insulin fail to give the desirable 3: 1 proportional effect, it seemed desirable to prepare an insulin with 75 per cent slow effect and 25 per cent rapid effect, and to compare the control obtainable with it with the regulation secured with other forms of insulin therapy. Since the studies of Wauchope (9) and of Ulrich (10) suggested that insulins with intermediate activity can be made by mixing protamine zinc insulin and regular insulin, we returned to the study of mixtures. We previously had confirmed the observations of Bjuggren (11) , Masters (12) , and others, that when protamine zinc insulin and regular insulin are mixed in the proportions commonly employed in the combined method of therapy, all of the insulin is precipitated by the excess of protamine present. We therefore have not adopted the practice of Wilder (13) and his associates of using mixtures varying with each patient.
Several preparations having approximately the desired proportional effects were obtained by mixing various amounts of protamine zinc insulin and regular insulin. Standard protamine zinc insulin contains an excess of about 40 per cent of protamine. The amounts of soluble and of precipitated insulin present after admixture, and therefore the relative rapidity of action, depend upon the excess of protamine present, the quantities of the 2 insulins used, and the pH. The effects of the relative proportions have been well presented by Peck (14) . A mixture of equal parts results in combination of all of the excess protamine, and should leave 60 per cent of the regular insulin (i.e., 30 per cent of the total units) in soluble form. However, when such a mixture was centrifuged, all of the insulin was found to be precipitated. This resulted from the fact that the pH of the mixture was close to 5, the iso-electric point of insulin. Minor alterations, either to the acid to to the alkaline side of pH 5, resulted in uncertain amounts of the regular insulin remaining in solution. If equal parts of protamine zinc insulin and regular insulin were mixed and the pH adjusted to 7.2, this uncertainty was avoided, and the pH of the insulin is approximately that of the body fluids. Assay of this form of modified protamine zinc insulin revealed that 75 per cent of the insulin was precipitated, and 25 per cent was soluble.
This special modification was selected for further study because it contains the desirable proportion of 3 parts precipitated insulin to 1 part of soluble insulin. For convenience and clarity in the rest of this paper, it is referred to as "3: 1" insulin. 3 The characteristics of this insulin, compared with the other modified insulins studied and with standard insulins, are given in Table I .
METHOD OF INVESTIGATION
Each patient studied remained in the hospital on the metabolism ward for several weeks. A carefully weighed diet was given, and the diet was not changed throughout the study period. Likewise, no appreciable variation in 3 Our first preparations of this material were made in our laboratory. Most Seventeen of 22 fasting blood sugars (77 per cent) were lowest with market protamine zinc insulin. The shorter duration of activity is a desirable feature, at least to some extent, but the comparative curves (Figure 2) show that with equivalent doses, the clear insulin had too little sustained effect, at the same time exhibiting too little initial activity. If we had used enough of the clear insulin to obtain normal fasting blood sugars, we should certainly have had to resort to a midafternoon feeding, as have others (6), to prevent hypoglycemic reactions. On the average, blood sugars with clear protamine zinc insulin were 26 mgm. per cent higher fasting, 10 mgm. per cent higher at 10:30 a.m., 9 mgm. per cent lower at 2:30 p.m., 7 mgm. per cent lower at 7:30 p.m., and 14 mgm. per cent higher at midnight.
The general shapes of the curves obtained with clear protamine zinc insulin and with market protamine zinc insulin are dissimilar, the clear insulin allowing a rise after breakfast, as does turbid protamine zinc insulin, but causing a steep fall in the afternoon, and permitting a considerable rise during the night, so that the mid-afternoon sugar is lowest, rather than the fasting levels, as is true with market protamine zinc insulin.
With equivalent doses, market protamine zinc insulin gave better diabetic control than clear protamine zinc insulin, while the latter failed tQ exhibit the prompt morning action desired. The clear insulin caused too great an afternoon fall, and its duration of activity was too short, permitting fasting blood sugar levels higher than desirable.
"Three-to-one" modified protamine zinc insulin. This special insulin gave much better results than any other modified insulin we have investigated. We have divided this study into two parts: I. Comparison of "3: 1" insulin with equal doses of protamine zinc insulin. II. Comparison of "3: 1" insulin with combined regular and protamine zinc insulin regulation.
I. "Three-to-one" insulin when compared with market protamine zinc insulin in 11 patients gave better diabetic control, with a definite tendency to give lower blood sugars at mid-morning, midafternoon and early evening, slightly higher sugars at midnight, and equal fasting blood sugars. Thus, the desired objectives of lower blood sugars during the day, and avoidance of nocturnal hypoglycemia seem to be accomplished with this new protamine zinc insulin modification. The individual comparative blood sugar figures are given in Table II. The average blood sugar rise permitted after breakfast by protamine zinc insulin was 78 mgm. per cent, while with "3: 1" insulin it was only 50 mgm. per cent. At 2:30 p.m., the average blood sugar after "3: 1" insulin was 16 mgm. per cent lower, at 7:30 p.m. 4 mgm. per cent lower, at midnight 10 mgm. per cent higher, while the fasting blood sugars gave almost exactly the same aver- Statistical analysis of these figures indicates that the better results obtained with the "3:1" insulin are not due to sampling error. At 10:30 a.m., for example, the time of the most definite improvement in the 24-hour blood sugar curves, the statistical probable significance of the differences is 0.978. According to Fisher's formula, a result of 0.95 or greater is statistically significant. age as with protamine zinc insulin. When compared with equal doses of market protamine zinc insulin in the 11 patients, fasting blood sugars were slightly lower with "3: 1" insulin in 20 per cent of the determinations, slightly higher in 41 per cent, equal (within 10 mgm. per cent) in 39 per cent. The blood sugars at 10:30 a.m. were lower with "3: 1" insulin 6 times out of 11, equivalent 4 times, slightly lower with protamine zinc insulin once. At 2:30 p.m. likewise, "3: 1" insulin gave the lowest blood sugars 6 times out of 11, equivalent 4 times, while protamine zinc insulin gave a slightly lower figure once. At 7:30 p.m., the "3: 1" insulin gave the lowest figures 6 times, protamine zinc insulin 3 times, while they were equivalent twice. At midnight, the "3: 1" insulin gave the lowest figures 7 times, protamine zinc 3 times, while they were equivalent once. Examination of the composite curves ( Figure 3 ) reveals that there is great similarity between the actions of the 2 insulins, except for the definite tendency to greater depression of the blood sugar during the day exhibited by the "3 to 1" protamine zinc insulin modification. II. Comparison of "3: 1" insulin with combined protamine zinc and regular insulin therapy: 6 patients showed as good regulation, or better, with "3: 1" insulin as with combined therapy. In each of these 6 cases, the best possible regulation was secured with a larger dose of protamine zinc insulin and a smaller dose of regular insulin, and then 24-hour blood sugar curves were obtained. Table III .
DISCUSSION
Some workers (7, 10) have obtained encouraging results with insulin-protamine zinc insulin mixtures, without readjustment of the pH to that of body tissues. If the resultant pH is near 5, the iso-electric point of insulin, all of the insulin is in precipitated form. Peck (14) has shown that buffering to pH 7.2, of a mixture of 2 parts of insulin with 1 part of protamine zinc insulin, results in 50 per cent of the insulin being present in rapidly-acting form. It would seem possible that the change to pH 7.2, occurring after subcutaneous injection of unbuffered mixtures, might result in the release of excess amounts of rapidly acting insulin. We have observed blood sugar responses suggesting this in a few patients treated with such preparations.
Insulin made by mixing equal parts of protamine zinc insulin and regular insulin with buffer added to adjust the pH to 7.2, provides a preparation containing 3 parts of precipitated insulin to 1 part of soluble insulin. This "3:1" insulin is stable, and since its pH is that of the body fluids, there is no variable factor resulting from pH change after injection. When small doses were 1. Comparative studies on 17 diabetic patients with a new modification of protamine zinc insulin gave better results than those obtained with the usual forms of insulin therapy. A single injection daily took the place of standard protamine zinc insulin in regulating patients with mild diabetes. One injection was also sufficient to control more severe diabetes, previously requiring separate injections daily of protamine zinc insulin and regular insulin.
2. Comparative studies on 18 patients with histone zinc insulin revealed poorer diabetic control than that obtained with standard protamine zinc insulin. The desirable more rapid initial action was lacking, and there was less prolonged effect.
3. Comparative studies on 11 patients with clear (acid or soluble) protamine zinc insulin gave less satisfactory control than that secured with standard protamine zinc insulin. Clear protamine zinc insulin had too little sustained effect and showed insufficient rapid activity.
4. A new insulin modification containing 3 parts of precipitated insulin to 1 part of soluble insulin provided better control in the patients studied than that obtained with other modifications or combinations of insulin. It is made by mixing equal parts of protamine zinc insulin and regular insulin with buffer added to adjust the pH to 7.2.
5. Multiple forms of insulin are not necessary, and their use should be discouraged. Two forms of insulin should be sufficient: (1) a modified protamine zinc insulin such as that described in these studies, used for controlling uncomplicated diabetes; (2) regular (or crystalline) insulin, to be employed whenever emergency therapy is necessary. BIBLIOGRAPHY 
